The Engelberg Organization
Director
Rochelle Cooper Dreyfuss is the Pauline Newman Professor of Law at NYU School of Law. Her research and teaching interests include intellectual property, civil procedure, privacy, and the relationship between science and law. She holds B.A. and M.S. degrees in Chemistry and was a research chemist before entering Columbia University School of Law, where she served as Articles and Book Review Editor of the Law Review. After graduating, she was a law clerk to Chief Judge Wilfred Feinberg of the U.S. Court of Appeals for the Second Circuit and to Chief Justice Warren E. Burger of the U.S. Supreme Court. She was a consultant to the Federal Courts Study Committee, to the Presidential Commission on Catastrophic Nuclear Accidents, and to the Federal Trade Commission. She served on two committees of the National Academy of Sciences, one on Intellectual Property in Genomic and Protein Research and Innovation; the other on Intellectual Property Rights in the Knowledge-Based Economy. She is a Reporter for the American Law Institute's Project on Intellectual Property: Principles Governing Jurisdiction, Choice of Law, and Judgments in Transnational Disputes.
Chair
Judge Pauline Newman of the United States Court of Appeals for the Federal Circuit chairs the Advisory Council. She is a 1958 graduate of the Law School, and holds a B.A. degree from Vassar College, an M.A. in Pure Science from Columbia University, and a Ph.D. degree in chemistry from Yale University. She has worked as a research scientist, and for many years served as Director of chemical patents, trademarks, and licensing for the FMC Corporation. She held office in several bar associations, and served on several Presidential advisory committees concerning United States and international intellectual property before her appointment to the Federal Circuit in 1984.
Donor
Alfred B. Engelberg graduated cum laude from NYU School of Law in 1965 after receiving a B.S. degree in chemical engineering from Drexel University. During a legal career of more than 30 years, he was an examiner in the Patent and Trademark Office, a patent agent for a major oil company, a patent trial attorney in the Department of Justice, and a partner in a private practice specializing in intellectual property litigation. As counsel to the generic drug industry, he was heavily involved in the negotiations leading to the major pieces of patent legislation enacted by Congress since the early 1980s.